SEC 13F Intelligence

Altium Capital Management LLC / COGT

Altium Capital Management LLC’s Cogent Biosciences Inc Position

Does Altium Capital Management LLC own Cogent Biosciences Inc (COGT)? Not currently — the last reported position was 235.0K shares worth $2M in Q3 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q3 2023
Shares
235.0K
% of Portfolio
+1.19%
Quarters Held
3
position exited

Position History COGT

Reported value by quarter
Q4 ’20: $5MQ4 ’20Q2 ’23: $3MQ2 ’23Q3 ’23: $2MQ3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2023235.0K$2M+1.19%
Q2 2023235.0K$3M+2.11%
Q4 2020432.6K$5M+1.81%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of COGT.